PharmX Technologies Limited (ASX:PHX)
| Market Cap | 69.24M +27.1% |
| Revenue (ttm) | 7.65M -11.4% |
| Net Income | -931.00K |
| EPS | -0.00 |
| Shares Out | 659.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 88,276 |
| Open | 0.1100 |
| Previous Close | 0.1100 |
| Day's Range | 0.1050 - 0.1100 |
| 52-Week Range | 0.0840 - 0.2000 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |
About PharmX Technologies
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in S... [Read more]
Financial Performance
In fiscal year 2025, PharmX Technologies's revenue was 7.53 million, a decrease of -6.97% compared to the previous year's 8.09 million. Losses were -264,000, -85.08% less than in 2024.
Financial StatementsNews
PharmX Technologies Slides: FY 2026
PharmX Technologies has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 16, 2026.
PharmX Technologies Earnings Call Transcript: H1 2026
Revenue grew 3% to AUD 3.9 million with strong Marketplace and New Zealand performance, positive EBITDA, and a major strategic partnership with Sigma Chemist Warehouse. Marketplace adoption and supplier integration surged, supporting future growth.
PharmX Technologies Quarterly report: H1 2026
PharmX Technologies has published its H1 2026 quarterly earnings report on February 24, 2026.
PharmX Technologies Slides: H1 2026
PharmX Technologies has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 24, 2026.
PharmX Technologies Earnings release: H1 2026
PharmX Technologies released its H1 2026 earnings on February 24, 2026, summarizing the period's financial results.
PharmX Technologies Earnings Call Transcript: H2 2025
FY 2025 delivered 13% revenue growth, strong platform expansion, and improved cash flow, despite higher investment. Marketplace and AI-driven initiatives are set to drive FY 2026 growth, with a stable cost base and robust market position.
PharmX Technologies Annual report: H2 2025
PharmX Technologies has published its H2 2025 annual report on August 19, 2025.
PharmX Technologies Slides: H2 2025
PharmX Technologies has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 19, 2025.
PharmX Technologies Earnings release: H2 2025
PharmX Technologies released its H2 2025 earnings on August 19, 2025, summarizing the period's financial results.